首页> 美国卫生研究院文献>Frontiers in Nutrition >An Improved Enzyme-Linked Immunosorbent Assay (ELISA) Based Protocol Using Seeds for Detection of Five Major Peanut Allergens Ara h 1 Ara h 2 Ara h 3 Ara h 6 and Ara h 8
【2h】

An Improved Enzyme-Linked Immunosorbent Assay (ELISA) Based Protocol Using Seeds for Detection of Five Major Peanut Allergens Ara h 1 Ara h 2 Ara h 3 Ara h 6 and Ara h 8

机译:改进的基于酶联免疫吸附测定(ELISA)的协议使用种子检测五种主要花生过敏原Ara h 1Ara h 2Ara h 3Ara h 6和Ara h 8

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peanut allergy is an important health concern among many individuals. As there is no effective treatment to peanut allergy, continuous monitoring of peanut-based products, and their sources is essential. Precise detection of peanut allergens is key for identification and development of improved peanut varieties with minimum or no allergens in addition to estimating the levels in peanut-based products available in food chain. The antibody based ELISA protocol along with sample preparation was standardized for Ara h 1, Ara h 2, Ara h 3, Ara h 6, and Ara h 8 to estimate their quantities in peanut seeds. Three different dilutions were optimized to precisely quantify target allergen proteins in peanut seeds such as Ara h 1 (1/1,000, 1/2,000, and 1/4,000), Ara h 2 and Ara h 3 (1/5,000, 1/10,000, and 1/20,000), Ara h 6 (1/40,000, 1/80,000, and 1/1,60,000), and Ara h 8 (1/10, 1/20, and 1/40). These dilutions were finalized for each allergen based on the accuracy of detection by achieving <20% coefficient of variation in three technical replicates. This protocol captured wide variation of allergen proteins in selected peanut genotypes for Ara h 1 (77–46,106 μg/g), Ara h 2 (265–5,426 μg/g), Ara h 3 (382–12,676 μg/g), Ara h 6 (949–43,375 μg/g), and Ara h 8 (0.385–6 μg/g). The assay is sensitive and reliable in precise detection of five major peanut allergens in seeds. Deployment of such protocol allows screening of large scale germplasm and breeding lines while developing peanut varieties with minimum allergenicity to ensure food safety.
机译:花生过敏是许多人中重要的健康问题。由于没有对花生过敏的有效治疗方法,因此持续监测花生基产品及其来源至关重要。精确检测花生过敏原是识别和开发具有最小或没有过敏原的改良花生品种的关键,此外还可以估计食物链中花生基产品的含量。基于抗体的ELISA方案以及样品前处理已针对Ara h 1,Ara h 2,Ara h 3,Ara h 6和Ara h 8进行了标准化,以估计其在花生种子中的含量。优化了三种不同的稀释液以精确定量花生种子中的目标过敏原蛋白,例如Ara h 1(1 / 1,000、1 // 2,000和1 / 4,000),Ara h 2和Ara h 3(1 / 5,000,1 / 10,000,和1 / 20,000),Ara h 6(1 / 40,000、1 / 80,000和1 / 1,60,000)和Ara h 8(1 / 10、1 / 20和1/40)。通过在三个技术重复试验中达到<20%的变异系数,根据检测的准确性最终确定每种变应原的稀释度。该协议捕获了花生基因型中Ara h 1(77–46,106μg/ g),Ara h 2(265–5,426μg/ g),Ara h 3(382–12,676μg/ g),Ara h 3(382–12,676μg/ g),Ara h 3 h 6(949–43,375μg/ g)和Ara h 8(0.385–6μg/ g)。该方法灵敏可靠,可精确检测种子中的五种主要花生过敏原。部署该方案可以筛选大规模种质和育种系,同时开发出具有最低致敏性的花生品种,以确保食品安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号